Navigation Links
OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
Date:4/23/2012

SAN DIEGO, April 23, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe. The study demonstrated the therapy's ability to provide local tumor control and quality of life outcomes that compare favorably to standard outcomes associated with surgery. These results were presented at the 5th European Conference on Head and Neck Oncology in Poznan, Poland on Friday, April 20, 2012.

(Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

The primary goal of this phase IV head and neck cancer study was to assess the ability of the OMS ElectroChemotherapy to control growth or recurrence of the cancer eight months following treatment, equivalent to surgery as compared to historical controls, with respect to primary (new) tumors and locally recurrent tumors. In this interim analysis, local tumor control was achieved in 46/49 (94%) primary tumors and 12/21 (57%) recurrent tumors. This meant that there was no recurrence of the tumors during the monitoring period. These were excellent results that were on par with the expected outcomes of surgery. Furthermore, evaluation of safety using the OMS ElectroChemotherapy for this patient population demonstrated that the treatment was safe and well-tolerated with no grade three or higher adverse events related to treatment reported during this study.

In addition, the secondary endpoint of preservation of organ function and appearance using validated quality of life instruments demonstrated a positive
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. OncoSec Selected to Present Data at Upcoming Head and Neck Cancer Conferences
2. OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial
3. OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy
4. OncoSecs OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper
5. OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma
6. OncoSec to Present at World Cancer Immunotherapy Conference
7. OncoSec to Present at the 22nd Annual Oppenheimer Healthcare Conference
8. OncoSec to Present at 15th Annual Biotech and Specialty Pharmaceuticals Conference
9. OncoSec and Serametrix Collaborate to Identify Potential Biomarkers to Enhance Skin Cancer Immune Therapies
10. OncoSec to Present at Medical Device Investor Forum
11. Device Master File for OncoSec Medical System Completed and Submitted to FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... and NEW YORK , June 18, 2013 ... BDX ) are accelerating the development of new ... technologies through a new collaboration announced today. This new, three-year ... type 1 diabetes (T1D). Many patients with T1D ... requiring a catheter to be placed in the body for ...
(Date:6/18/2013)... -- Healthgrades, the leading online resource that helps consumers ... hospitals, today issued the Healthgrades Women,s Health ... to Get Your Best Outcome . The report, which ... gynecologic surgery, as well as hospitals that excelled ... the most common hospital-based conditions and procedures, urges ...
(Date:6/18/2013)... Apama Medical, a privately held medical ... atrial fibrillation technologies, today announced the issuance of ... and Trademark Office (USPTO), titled "Low Profile Electrodes". ... use on expandable structures such as balloons used ... "We are grateful to the NSF SBIR ...
Breaking Medicine Technology:JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4
... CID s.r.l., a European company leader in interventional medicine, ... revolutionary drug eluting stent technology during The Drug Eluting ... Wednesday, September 22, 2010.  The lecture, entitled "Status of ... by Alexandre Abizaid, MD, PhD. Chief of Intervention at ...
... pleased to announce the addition of Kenneth ... to further the advancement of the group,s minimally invasive ... neurostimulators . Dr. Alo will serve as Director of ... graduated from Texas A&M University College of Medicine and ...
Cached Medicine Technology:CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010 2Kenneth Alo, M.D., Joins Ascendant Neuro as Director of Neuromodulation and Clinical Research 2Kenneth Alo, M.D., Joins Ascendant Neuro as Director of Neuromodulation and Clinical Research 3
(Date:6/18/2013)... Center clinical researchers have launched an innovative clinical ... the ability of a patient,s own stem cells ... arterial disease (PAD). , Led by Vik ... Hospitals Case Medical Center,s Harrington Heart & Vascular ... Reserve University School of Medicine, the clinical trial ...
(Date:6/18/2013)... 2013 The July 2013 issue of Marie ... Getting Beach Ready,” offers a list of home and doctor’s ... in a bathing suit this summer. The list includes treatment ... smoothing cellulite , and more. (go to goo.gl/aIe4J). , ... of Epione Beverly Hills, “though I would say some of ...
(Date:6/18/2013)... Atlanta (PRWEB) June 18, 2013 ... Cypress Care, ScripNet and Procura Management, today announced ... of chief sales officer. In this position, Leonardo ... support of the company’s strategic growth initiatives. , ... his leadership and expertise, Leonardo brings more than ...
(Date:6/18/2013)... 18, 2013 David Connett, DO, vice ... Medicine for the College of Osteopathic Medicine of the ... been elected president of the Osteopathic Medical Board ... Jr. appointed Connett, a 1984 alumnus of COMP, to ... elected Connett to the position during a conference call. ...
(Date:6/18/2013)... in the mammary gland appear to provide a crucial ... life, and the subsequent development of breast cancer, researchers ... 2013 issue of the journal Cancer Prevention Research ... associated with an increased risk of certain types of ... of social stress to cancer have been hard to ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Skin Care – Getting Your Body Beach Ready 2Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4
... replacement therapy (HRT) may increase the risk of developing asthma ... of print in the journal Thorax . The ... quizzed about their use of HRT and development of asthma ... the women were taking part in the French E3N study, ...
... ... capture the authentic heartbeat of NY Jets Quarterback Mark Sanchez for a CBS Cares public ... is a favorite in broadcasting - this may be the biggest audience to hear the ... ...
... ... The inaugural meeting of The Global Leaders, a networking group of influential ... prestigious Yale Club in New York City on February 9th. There are ... companies, with more than $700 billion in annual revenue, $5 trillion in ...
... ... provider of trace level detection technologies based on the exploitation of Surface-Enhanced ... it has appointed David Burns as its new Chief Executive Officer. He ... diagnostic (IVD) products, with the aim to establish D3 Technologies as a ...
... to take steps to prevent illness , SATURDAY, Feb. 6 ... Vancouver can be champions of their health by following some ... the U.S. Centers for Disease Control and Prevention. , The ... by remembering to "Stop, Wash and Go:" , Stop. ...
... ... the St. Louis Jewish Community Center , ... St. Louis, MO (PRWEB) February 7, 2010 -- The Museum of ImaJewnation will ... located inside the St. Louis Jewish Community Center, Staenberg Family Complex Arts & Education Building ...
Cached Medicine News:Health News:Estrogen-only HRT may increase risk of asthma after menopause 2Health News:Superbowl Heartbeat from Thinklabs Electronic Stethoscope 2Health News:Global Leaders Hold Inaugural Meeting in New York City on February 9, 2010 2Health News:Ground Breaking Molecular Diagnostics Business Appoints New CEO 2Health News:Ground Breaking Molecular Diagnostics Business Appoints New CEO 3Health News:Spectators Need to Prepare for Olympic Games, Too 2
... catheters are designed using established technology ... following benefits:, ,Working with pH ... where the multi-use catheter is used ... contact to the skin.,NOTE: ,Medtronic pH ...
... Slimline single-use pH catheters are ... cross-contamination and allow greater patient comfort ... ,Medtronic pH measurement systems have been ... that allow an accurate room-temperature calibration. ...
The WaveMax is one of the most flexible stainless steel stents due to its unique wave design and has the lowest effective profile, accommodating a 6F sheath up to 7 mm....
... the world of online quality control ... control information and peer group statistics ... introduces a revolutionary internet based format ... Why rely on traditional quality control ...
Medicine Products: